These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34730093)

  • 1. Good Clinical Practice (GCP) - an alternative, unarticulated narrative.
    Malhotra S
    Indian J Med Ethics; 2022; VII(2):119-122. PubMed ID: 34730093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
    Browne LH; Graham PH
    Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
    Ebi O
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholders' recommendations for revising Good Clinical Practice.
    Corneli A; Forrest A; Swezey T; Lin L; Tenaerts P
    Contemp Clin Trials Commun; 2021 Jun; 22():100776. PubMed ID: 33997463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholders' views on the most and least helpful aspects of the ICH E6 GCP guideline and their aspirations for the revision of ICH E6(R2).
    Dombeck C; Swezey T; Forrest A; Tenaerts P; Corneli A
    Contemp Clin Trials Commun; 2022 Oct; 29():100983. PubMed ID: 36111176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences with GCP in the pharmaceutical industry [corrected].
    Rämsch KD
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):237-40. PubMed ID: 8240533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO guidelines for good clinical practice (GCP) for trials on pharmaceutical products: responsibilities of the investigator.
    Idänpään-Heikkilä JE
    Ann Med; 1994 Apr; 26(2):89-94. PubMed ID: 8024733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The norms for good clinical practice in drug trials performed in Spain. A survey of the pharmaceutical industry].
    Segú JL; Lahuerta dal Ré J
    Med Clin (Barc); 1992 Jun; 99(3):106-9. PubMed ID: 1630197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Good clinical practice (GCP)].
    Hvidberg E; Dirach J
    Theriaca; 1998 Sep; 31():7-53. PubMed ID: 11625363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)].
    Eckhardt K; Cremer-Schaeffer P; König J; Paeschke N
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):173-80. PubMed ID: 15726458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Performing clinical trials efficiently in Japan--independent clinical trials and GCP].
    Kanai M; Suzuki-Nishimura T
    Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):449-54. PubMed ID: 17644939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Russ H; Busta S; Jost B; Bethke TD
    Ger Med Sci; 2015; 13():Doc02. PubMed ID: 25698912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The roles and responsibilities of the pharmaceutical industry].
    Dejgaard A; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles of good clinical practice (GCP) in clinical research.
    Switula D
    Sci Eng Ethics; 2000 Jan; 6(1):71-7. PubMed ID: 11273440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.